What is the ICD‑10‑CM code for a cervical cancer screening encounter?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ICD-10-CM Code for Cervical Cancer Screening

The ICD-10-CM code for a routine cervical cancer screening encounter is Z12.4. 1

When to Use Z12.4

  • Z12.4 is the appropriate code for asymptomatic women presenting specifically for routine preventive cervical cancer screening, including Pap tests, HPV testing, or co-testing. 1

  • This code should only be used for women without symptoms who are coming in for their scheduled screening visit. 1

When NOT to Use Z12.4

Do not use Z12.4 in the following situations:

  • Women presenting with symptoms (bleeding, discharge, pain) - use the code for the presenting symptom instead. 1

  • Follow-up visits for previously abnormal results - use the appropriate code for the abnormal finding rather than the screening code. 1

  • Women with a history of abnormal findings requiring intensive surveillance - use Z87.410 instead. 1

  • Women who have had total hysterectomy with cervix removal for benign disease - these patients should not receive screening, so Z12.4 is not appropriate. 1

Alternative Codes for Specific Situations

  • Z11.51: Use when HPV testing is the primary focus of the visit. 1

  • Z87.410: Use for women with a history of abnormal findings who require more intensive surveillance rather than routine screening. 1

  • Z77.9: Use for women with DES exposure requiring continued screening. 1

Key Clinical Context

The screening code Z12.4 applies to women undergoing routine screening according to current guidelines, which recommend cytology every 3 years for ages 21-29, and primary HPV testing every 5 years (preferred) or co-testing every 5 years for ages 30-65. 2

References

Guideline

Cervical Cancer Screening Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Cervical Cancer Screening Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

In a cervical cancer screening study that intends to keep results blinded, which approach will satisfy the ethics review board: informing participants with a positive screening result and directing them to diagnostic follow‑up?
Which level of prevention (primordial, primary, secondary, or tertiary) applies to a patient with asymptomatic vaginal discharge who is offered a Pap smear for cancer screening?
What is the management plan for a patient with a history of cervical cancer, currently without evidence of disease spread or active bleeding?
What is the primary approach to managing a patient with HPV (Human Papillomavirus)-negative cervical adenocarcinoma?
What are the treatment options for cervical cancer stage 1b1?
How should I manage an asymptomatic 25‑year‑old healthy male with borderline hypertension, tachycardia, and sinus arrhythmia on electrocardiogram?
What is the appropriate intravenous dosing of piperacillin‑tazobactam (Tazocin) based on the patient's estimated glomerular filtration rate (eGFR)?
How should anemia be defined, evaluated, and managed, including appropriate workup and treatment options?
What are the Current Procedural Terminology (CPT) codes for a Pap smear (Papanicolaou test) and a clinical breast examination?
In a 28‑week pregnant woman with isolated low free triiodothyronine (FT3) but normal free thyroxine (FT4) and thyroid‑stimulating hormone (TSH), is treatment indicated?
How can mild acute pancreatitis present with normal serum amylase and lipase and unremarkable abdominal ultrasound or computed tomography, and what is the recommended initial management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.